Teresa Brophy Bair sold $89K of Kura Oncology stock
By AlphaYouPublished Form 4
Bair Teresa Brophy
Reporting filer
Teresa Brophy Bair reported selling 8,442 shares of Kura Oncology, Inc. for about $89K ($10.50 a share on average). Form 4 filed Sep 29, 2026 lists 1 entry.
See the price move since this trade →
- Disclosed
- Sep 29, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Bair Teresa Brophy | 2026-09-28 | S | Sale | 8442 | 10.4973 | 187,002 | 1 day | Filed terms
|
Common Stock
- Owner
- Bair Teresa Brophy
- Date
- 2026-09-28
- Code
- S
- Action
- Sale
- Quantity
- 8442
- Price
- 10.4973
- Following holdings
- 187,002
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-28
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: false
- id: F1
- transaction Shares: 8442
- transaction Price Per Share: 10.4973
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 187002
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Bair Teresa Brophy: Chief Legal Officer.
- The filing reports a Rule 10b5-1 trading plan.
- F1: Sell-to-cover for taxes associated with the vesting of 1/6th of the underlying shares of performance-based restricted stock units ("PSUs") granted to the Reporting Person on May 31, 2023. Each PSU represents the contingent right to receive one share of the Issuer's common stock based on the achievement of each of three specified development milestones, and the one-year anniversary of each milestone achievement, subject to the Reporting Person's continuous service on each corresponding vesting date. The one-year anniversary of the specified development milestone was determined to be met on September 27, 2026, resulting in the vesting of 1/6th of the underlying shares.
Original sources
Prepared automatically from public filing data. Report a correction.